secwatch.observer — SEC 8-K summary
======================================

Issuer:     Odyssey Health, Inc. (ODYY)
CIK:        0001626644
Form:       8-K
Filed at:   2025-10-17T23:59:59+00:00
Accession:  0001683168-25-007644
Event type: other_material
Sentiment:  positive
Materiality: 0.60
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Odyssey Health signs exclusive worldwide sub-license for BreastCheck non-invasive breast test
--------------------------------------------------------------------------------

- Sub-license grants exclusive global marketing and distribution rights for BreastCheck, a 15-minute at-home test.
- BreastCheck is FDA registered in the US and registered in EU and UK; targets $26B breast cancer diagnostics market.
- Deal managed through subsidiary Odyssey Medical Devices; subject to closing conditions.
- CEO expects near-term commercialization and initial revenue, marking transition from development-stage to revenue-generating.
- No financial terms (upfront fee, milestones, royalties) disclosed in the filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1626644/000168316825007644/0001683168-25-007644-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1626644/000168316825007644/odyssey_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-25-007644

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer